Literature DB >> 11553644

Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus.

D H Sweet1, D S Miller, J B Pritchard.   

Abstract

To determine whether organic cation transporter (OCT) family members might mediate choline transport in choroid plexus (CP), the handling of choline by cloned transporters and by intact CP isolated from the adult rat was investigated. Expression of OCT1 and OCT2 in Xenopus oocytes increased hemicholinium-3-sensitive choline uptake. In contrast, OCT3 did not mediate choline transport. Estimated K(m) values for choline in rOCT1-, rOCT2-, and hOCT2-expressing oocytes were 346 +/- 50, 441 +/- 67, and 102 +/- 80 microm, respectively. Membrane potential was the major driving force for choline uptake in rat and human OCT2-expressing oocytes and in intact CP in vitro. Lowering of medium pH (6 versus 7.4) was equally effective at inhibiting choline uptake in CP, suggesting that there might be a non-OCT component of choline uptake that is responsive to an H(+) gradient. However, choline efflux from CP was not stimulated by a trans-applied H(+) gradient. Choline uptake by CP was Na(+)-independent with an estimated K(m) of 183 microm. Reverse transcriptase-polymerase chain reaction detected OCT2 and OCT3, but not OCT1, mRNA expression in CP. Transfection of intact CP with a rOCT2/green fluorescent protein fusion construct resulted in strong apical membrane fluorescence with no detectable signal in the basal and lateral plasma membranes. These data indicate that OCT2 mediates choline transport across the ventricular membrane of CP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553644     DOI: 10.1074/jbc.M108472200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

Review 2.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

3.  Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties.

Authors:  Lewis Zhichang Shi; G Jane Li; Shunzhen Wang; Wei Zheng
Journal:  Toxicol In Vitro       Date:  2007-07-28       Impact factor: 3.500

Review 4.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

5.  Choline transport links macrophage phospholipid metabolism and inflammation.

Authors:  Shayne A Snider; Kaitlyn D Margison; Peyman Ghorbani; Nicholas D LeBlond; Conor O'Dwyer; Julia R C Nunes; Thao Nguyen; Hongbin Xu; Steffany A L Bennett; Morgan D Fullerton
Journal:  J Biol Chem       Date:  2018-06-07       Impact factor: 5.157

Review 6.  Inner blood-retinal barrier transporters: role of retinal drug delivery.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

7.  Stress-induced stimulation of choline transport in cultured choroid plexus epithelium exposed to low concentrations of cadmium.

Authors:  Robin K Young; Alice R A Villalobos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-08       Impact factor: 3.619

Review 8.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

9.  Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.

Authors:  Haichuan Duan; Joanne Wang
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

10.  Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.

Authors:  Britta Haenisch; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.